{"id":"W2522960478","doi":"10.1016/s0168-8278(16)01707-4","title":"RETRACTED: PS 124 - Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease","year":2016,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":7,"is_retracted":true,"has_abstract":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Vedolizumab; Primary sclerosing cholangitis; Inflammatory bowel disease; Medicine; Dosing; Gastroenterology; Ulcerative colitis; Internal medicine; Inflammation; Disease; Biliary disease; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":{"nature":"Retraction","reason":"Concerns/Issues about Data;Unreliable Results and/or Conclusions;","date":"12/15/2016 0:00","openalex_flagged":true},"screen":null}